|
Market Closed -
Nasdaq
04:00:00 2026-10-02 pm EDT
|
5-day change | 1st Jan Change | ||
| 10.50 USD | -6.75% |
|
-10.79% | -33.04% |
| Oct. 01 | Monte Rosa Therapeutics Announces Positive Data From GFORCE-1 Phase 1 Study Evaluating MRT-8102 | CI |
| Oct. 01 | Monte Rosa Therapeutics, Inc. - Special Call |
Chart calendar Monte Rosa Therapeutics, Inc.
Upcoming events on Monte Rosa Therapeutics, Inc.
No events available
Past events on Monte Rosa Therapeutics, Inc.
| 2026-10-01 | Information meeting | 08:00 am |
| 2026-06-11 | Présentation aux Actionnaires / Analystes | 08:30 am |
| 2026-06-11 | Annual General Meeting | 08:30 am |
| 2026-01-07 | Information meeting | 08:00 am |
| 2025-12-16 | Information meeting | 08:00 am |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 15,1 - | 75,6 59,8 26.51% | 124 136 -9.37% | 67,4 | 53,9 | 102 |
|
EBITDA Million USD | Released Forecast Spread | -137 -93,4 -46.8% | -73,0 -143 48.9% | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -143 -131 -9.04% | -81,1 -89,3 9.18% | -54,2 -34,7 -56.23% | -169 | -223 | -208 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -135 -123 -9.41% | -70,1 -78,8 11.01% | -39,7 -20,7 -91.89% | -148 | -207 | -193 |
|
Net income Million USD | Released Forecast Spread | -135 -124 -9.53% | -72,7 -78,9 7.87% | -38,6 -21,5 -79.63% | -150 | -207 | -196 |
|
EPS USD | Released Forecast Spread | -2,63 -2,42 -8.79% | -0,98 -1,25 21.87% | -0,46 -0,26 -78.28% | -1,48 | -1,97 | -1,73 |
| Announcement Date | 14/03/24 | 20/03/25 | 17/03/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 60,6 51,2 18.47% | 84,9 13,6 526.01% | 23,2 7,37 214.67% | 12,8 7,37 73.21% | 2,78 15,5 -82.07% | 4,21 11,4 -63.02% | 8,97 12,9 -30.36% | 31,5 | 23,2 | 4,70 | 4,70 | 5,60 | 5,60 |
|
EBIT Million USD | Released Forecast Spread | 13,0 7,41 75.42% | 44,0 -32,2 236.91% | -15,6 -33,0 52.94% | -33,0 -32,2 -2.43% | -49,7 -30,2 -64.52% | -50,0 -42,5 -17.87% | -49,1 -43,4 -13.1% | -29,5 | -40,6 | -65,4 | -68,9 | -70,0 | -73,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 15,6 9,79 59.29% | 47,7 -29,6 261.38% | -11,1 -29,8 62.78% | -30,3 -28,7 -5.52% | -46,1 -27,0 -70.46% | -44,5 -38,0 -17.08% | -43,2 -38,5 -12.14% | -24,2 | -36,4 | -60,9 | -65,1 | -66,5 | -70,2 |
|
Net income Million USD | Released Forecast Spread | 13,4 9,79 37.2% | 46,9 -29,6 258.6% | -12,3 -29,8 58.76% | -27,1 -28,7 5.56% | -46,1 -28,4 -62.35% | -44,5 -38,0 -17.22% | -43,4 -38,5 -12.68% | -24,4 | -37,3 | -61,0 | -65,2 | -66,6 | -70,2 |
|
EPS USD | Released Forecast Spread | 0,27 0,01 1735.49% | 0,57 -0,34 269.28% | -0,15 -0,38 60.17% | -0,33 -0,37 10.02% | -0,55 -0,35 -56.73% | -0,45 -0,38 -18.53% | -0,43 -0,38 -12.73% | -0,24 | -0,36 | -0,60 | -0,63 | -0,64 | -0,66 |
| Announcement Date | 20/03/25 | 08/05/25 | 07/08/25 | 06/11/25 | 17/03/26 | 07/05/26 | 06/08/26 | - | - | - | - | - | - |
| 2026-10-06 |  | Information meeting | |
| 2026-10-06 | | Analyst/Investor Day | 11:00 am |
| 2026-10-12 | | Analyst/Investor Day | |
| 2026-10-12 | | Extraordinary General Meeting | 10:00 pm |
| 2026-10-13 | | Earnings presentation | 10:00 pm |
| 2026-10-14 | | Analyst/Investor Day | 12:00 pm |
| 2026-10-18 | | Extraordinary General Meeting | 10:00 pm |
| 2026-10-20 | | Information meeting | 08:30 am |
| 2026-10-20 | | Analyst/Investor Day | |
| 2026-10-21 | | Earnings release - Q3 2026 |
Past sector events for Monte Rosa Therapeutics, Inc.
| 2026-09-30 | | Information meeting | 08:30 am |
| 2026-09-29 | | Extraordinary General Meeting | 10:00 pm |
| 2026-09-29 | | Earnings release - Q2 2026 | |
| 2026-09-28 | | Extraordinary General Meeting | 02:30 am |
| 2026-09-28 | | Extraordinary General Meeting | 02:30 am |
| 2026-09-24 | | Analyst/Investor Day | 09:00 am |
| 2026-09-24 | | Information meeting | 08:00 am |
| 2026-09-23 | | Extraordinary General Meeting | 09:00 am |
| 2026-09-23 | | Présentation aux Actionnaires / Analystes | 09:00 am |
| 2026-09-23 | | Extraordinary General Meeting | 03:00 am |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- GLUE Stock
- Calendar Monte Rosa Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
